Ann: FDA Grants Rare Pediatric Disease Designation for Revascor, page-75

NO Doc, you didn't say that, you never even mentioned the tradability of FDA designation vouchers until I provided some evidence of it above (even those others spoke of them too), but did presume to tell everyone they don't understand the process - as you do me now, when I provide substantiated data on the subject to Hot Copper readers on FDA designation of IP trading and valuation, that, dare I say, is a little more helpful than, of course, your given opinion and condescension.

I've said many times in your defence that you kop some unfair and often nasty abuse on here - but you do rather bring on it yourself at times....

Unequivocally good news for MSB (hence the 20%+ mkt move) and requiring re-evaluation of its IP as said.